Effect of the novel high-affinity glycine-site N-methyl-D-aspartate antagonist ACEA- 1021 on 125I-MK-801 binding after subdural hematoma in the rat: An in vivo autoradiographic study

Journal of Neurosurgery

Volumn 85, Issue 4, 1996, Pages 655-661

  Di, Xiao ^a   Bullock, Ross ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ACEA 1021; acute subdural hematoma; head injury; in vivo autoradiography; MK 801; N methyl D aspartate ion channel activation

Indexed keywords

6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; DIZOCILPINE; IODINE 125; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BINDING COMPETITION; CONTROLLED STUDY; HEAD INJURY; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SUBDURAL HEMATOMA;

EID: 0029791376     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.4.0655     Document Type: Article

References (34)

1. Andiné P, Jacobson I, Hagberg H: Enhanced calcium uptake by CA1 pyramidal cell dendrites in the postischemic phase despite subnormal evoked field potentials: excitatory amino acid receptor dependency and relationship to neuronal damage. J Cereb Blood Flow Metab 12:773-783, 1992
2. Baker AJ, Moulton RJ, MacMillan VH, et al: Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J Neurosurg 79:369-372, 1993
3. 3H]-MK-801 binding sites in mammalian brain. Br J Pharmacol 93:944-954, 1988
4. Boxer PA, Cordon JJ, Mann ME, et al: Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat. Stroke 21 (Suppl): III47-I1I51, 1990
5. Bullock R, Butcher S, McCulloch J: Changes in extracellular glutamate concentration after acute subdural haematoma in the rat - evidence for an "excitotoxic" mechanism? Acta Neurochir Suppl 51:274-276, 1990
6. Bullock R, Butcher SP, Chen MH, et al: Correlation of the extracellular glutamate concentration with extent of blood flow reduction after subdural hematoma in the rat. J Neurosurg 74: 794-802, 1991
7. Bullock R, Graham DI, Chen MH, et al: Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene. J Cereb Blood Flow Metab 10: 668-674, 1990
8. Bullock R, Maxwell WL, Graham DI, et al: Glial swelling following human cerebral contusion: an ultrastructural study. J Neurol Neurosurg Psychiatry 54:427-434, 1991
9. Bullock R, Teasdale GM, Kotake A, et al: Experience with the glutamate antagonist CGS19755 in severe human head injury: evidence for ICP lowering effect, in Nagai H, Kamiya K, Ishii S (eds): Intracranial Pressure IX. Tokyo: Springer-Verlag, 1994, pp 238-241
10. Bullock R, Zauner A, Tsuji O, et al: Patterns of excitatory amino acid release and ionic flux after severe human head trauma, in Tsubokawa T, Marmarou A, Robertson C, et al (eds): Neurochemical Monitoring in the Intensive Care Unit. Microdialysis, Jugular Venous Oximetry, and Near-Infrared Spectroscopy. Tokyo: Springer-Verlag, 1995, pp 64-71
11. Chen M, Bullock R, Graham DI, et al: Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia. Ann Neurol 30:62-70, 1991
12. Chen MH, Bullock R, Graham DI, et al: Ischemic neuronal damage after acute subdural hematoma in the rat: effects of pretreatment with a glutamate antagonist. J Neurosurg 74: 944-950, 1991
13. Choi DW, Koh J, Peters S: Pharmacology of glutamate neuroloxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci 8:185-196, 1988
14. Collins RC, Dobkin BH, Choi DW: Selective vulnerability of the brain: new insights into the pathophysiology of stroke. Ann Intern Med 110:992-1000, 1989
15. Crepel V, Represa A, Ben-Ari Y: Effect of ischemia and intra-amygdaloid kainate injection on the density of NMDA binding sites in the hippocampal CA1 region. Eur J Pharmacol 151: 355-356, 1988
16. Fujisawa H, Maxwell WL, Graham DI, et al: Focal microvascular occlusion after acute subdural haematoma in the rat: a mechanism for ischaemic damage and brain swelling? Acta Neurochir Suppl 60:193-196, 1994
17. Inglis F, Kuroda Y, Bullock R: Glucose hypermetabolism after acute subdural hematoma is ameliorated by a competitive NMDA antagonist. J Neurotrauma 9:75-84, 1992
18. Kuroda Y, Bullock R: Local cerebral blood flow mapping before and after removal of acute subdural hematoma in the rat. Neurosurgery 30:687-691, 1992
19. Kuroda Y, Dewar D, Bullock R: Early changes in second messenger but not receptor binding sites after acute subdural hematoma: an in vitro autoradiographic study. J Neurotrauma 10:47-55, 1993
20. Kuroda Y, Inglis FM, Miller JD, et al: Transient glucose hyper-metabolism after acute subdural hematoma in the rat. J Neurosurg 76:471-477, 1992
21. Lazarewicz JW, Salinska E, Wroblewski JT: NMDA receptor-mediated arachidonic acid release in neurons: role in signal transduction and pathological aspects. Adv Exp Med Biol 318: 73-89, 1992
22. Lyden PD, Hedges B: Protective effect of synaptic inhibition during cerebral ischemia in rats and rabbits. Stroke 23: 1463-1469, 1992
23. Martin H, Warner DS, Todd MM: Effects of glycine receptor antagonism on spreading depression in the rat. Neurosci Lett 180:285-289, 1994
24. McFarlane C, Warner DS, Nader A, et al: Glycine receptor antagonism. Effects of ACEA-1021 on the minimum alveolar concentration for halothane in the rat. Anesthesiology 82: 963-968, 1995
25. Miller JD, Bullock R, Graham DI, et al: Ischemic brain damage in a model of acute subdural hematoma. Neurosurgery 27: 433-439, 1990
26. Persson L, Hillered L: Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J Neurosurg 76:72-80, 1992
27. Stevens MK, Yaksh TL: Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEC, and blood-brain barrier following complete reversible cerebral ischemia. J Cereb Blood Flow Metab 10:77-88, 1990
28. Tombaugh GC, Sapolsky RM: Mechanistic distinctions between excitotoxic and acidotic hippocampal damage in an in vitro model of ischemia. J Cereb Blood Flow Metab 10: 527-535, 1990
29. Tsuchida E, Bullock R: The effect of the glycine site-specific N-methyl-D-aspartate antagonist ACEA 1021 on ischemic brain damage caused by acute subdural hematoma in the rat. J Neurotrauma 12:279-288, 1995
30. 3H-MK-801 (dizocilpine) in vivo uptake and in vitro binding after focal cerebral ischemia in the rat. J Neurosurg 76:127-133, 1992
31. Warner DS, Martin H, Ludwig P, et al: In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J Cereb Blood Flow Metab 15: 188-196, 1995
32. Warner MA, Neill KH, Nadler JV, et al: Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil. J Cereb Blood Flow Metab 11:600-610, 1991
33. Westerberg E, Monaghan DT, Kalimo H, et al: Dynamic changes of excitatory amino acid receptors in the rat hippo-campus following transient cerebral ischemia. J Neurosci 9: 798-805, 1989
34. Woodward RM, Huettner JE, Guastella J, et al: In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol Pharmacol 47: 568-581, 1995